Advances in Dentistry

Learning Goals

Gain an understanding of the latest developments in dental techniques, materials, and procedures, including:

• BlueCheck for detecting caries
• Gentle-Wave technology to enhance endodontic irrigation
• MTA sealer for endodontic applications
• Universal composites in a single shade
• Silver Diamine Fluoride (SDF) for effective caries management

Overview

The field of dental materials and techniques is continuously evolving, aiming to enhance patient care and outcomes. This course highlights several recently FDA-approved products and methodologies that have garnered interest among dental professionals, including both general practitioners and specialists. Our objective is to inform practitioners about these advancements, discussing their respective benefits, drawbacks, and practical uses. By acquiring this knowledge, clinicians can improve their practice, provide patients with a wider array of treatment options, and foster better communication between patients and dental providers. It is important to note that this course does not endorse any particular product or technique, and Dental Didactics maintains no financial ties to, nor receives any compensation from, any dental manufacturing entity.

Silver Diamine Fluoride

Dental caries continues to be the most prevalent infectious condition affecting humans. The primary bacterial strains responsible for this disease are Streptococcus mutans and Streptococcus sobrinus. Most current treatments for caries focus on restorative methods, addressing the consequences of the disease rather than eliminating the causative agents. In pediatric patients, caries can lead to significant issues that often necessitate extensive restorative care, sometimes requiring behavioral management techniques such as sedation or general anesthesia. The U.S. Food and Drug Administration (FDA) has cautioned against the potential serious side effects of these management techniques, particularly noting that prolonged or repeated use of general anesthesia in children under three years old could impact brain development.

Given the desire for less invasive and more affordable treatment options, the application of silver diamine fluoride (SDF) for caries management has recently gained considerable media attention in the U.S. An article from The New York Times titled “A Cavity-Fighting Liquid Lets Kids Avoid Dentists’ Drills” has highlighted this treatment option.

Although a 38% solution of silver diamine fluoride has been developed and utilized internationally for years, it has only recently become available in the United States. The silver content of SDF provides an antimicrobial effect, while fluoride contributes to remineralization, and ammonia serves as a stabilizer for the compound. The FDA approved SDF 38% for the treatment of dentinal hypersensitivity, a designation also granted to fluoride varnishes. Like fluoride varnishes, SDF is currently used "off-label" for caries control. In 2016, the FDA granted SDF 38% the Breakthrough Therapy designation for its effectiveness in arresting caries in both adults and children, based on reviews of global clinical trial results involving children aged 3 to 9 and adults aged 60 to 89.

The only commercially available SDF product in the U.S. is Advantage Arrest, manufactured by Elevate Oral Care. This solution is available in 8 mL dropper bottles or unit-dose ampules. A single drop (25 microliters) can treat up to five teeth, with each bottle containing about 250 drops.

The active components in SDF 38% solution (weight/volume) are:

• Silver: 25% (antibacterial properties)
• Ammonia: 8% (stabilizing agent)
• Fluoride: 5% (aids remineralization)

SDF works through several mechanisms, including:

• Interaction of silver ions with sulfhydryl groups of proteins, modifying hydrogen bonding
• Inhibition of bacterial respiration
• Prevention of bacterial cell wall synthesis
• Inhibition of bacterial DNA replication
• Denaturation of bacterial proteins
• Hardening of tooth structure by forming fluorapatite
• Suppression of biofilm formation

The SDF solution is typically odorless, with a slight ammonia scent, and possesses a bitter metallic taste and a pH of 10. It may appear clear or slightly tinted for easier visibility during application. Interestingly, exposure to just one drop of SDF results in less than half the absorbed fluoride content compared to a standard application of 0.25 mL fluoride varnish. Clinical trials involving over 4,000 children have shown no reports of significant adverse systemic effects, indicating a safety margin of 400-fold. However, SDF should not be used in patients with a known allergy to silver compounds.

International clinical trials focusing on the application of SDF 38% in pediatric populations have yielded promising results. The American Dental Association (ADA) recognizes seven completed trials demonstrating that SDF is effective in caries management and reduces the risk of caries in both treated and adjacent teeth. Furthermore, the ADA has acknowledged SDF's efficacy in managing root caries among the elderly. It can also serve as an interim solution to stabilize patients requiring lengthy treatment plans or those unable to complete complex cases at once.

SDF treatment targets the issue from two angles: eliminating bacteria and promoting remineralization and strengthening of tooth structure. Lesions treated with SDF show formation of hydroxyapatite and fluorapatite, as well as a reduction in the depth of demineralized areas. Treated lesions exhibit increased mineral density and hardness, making them more resistant to future decay. Positive outcomes from caries arrest in cervical lesions among older patients have been noted by the ADA; however, additional research is necessary to reach a consensus on its clinical application in geriatric dentistry. The FDA's designation of SDF as a Breakthrough Therapy will likely expedite research, particularly concerning the significant elderly population with untreated cervical caries.

Despite its advantages, there are several drawbacks associated with SDF usage:

• The primary concern is that SDF can stain teeth with carious lesions a dark, unattractive black color. This esthetic issue significantly hinders its acceptance, especially in the U.S., where cosmetic appearance is often prioritized over other considerations. The staining is permanent and does not diminish over time.
• A saturated solution of potassium iodide (SSKI) can be applied immediately after SDF to mitigate staining; however, its effectiveness is limited. Additionally, it cannot be used in pregnant women or during the first six months of breastfeeding due to the risk of overloading the thyroid gland with iodide. This use of SSKI is considered “off-label” and is approved primarily for mucus release and thyroid protection in radiation emergencies.
• SDF can stain materials such as lab coats, patient clothing, and hard surfaces (e.g., dental carts and operatory counters). Spills should be cleaned immediately using water, ethanol, or bleach.
• If SDF contacts the skin, it may cause a temporary henna-like discoloration for about two weeks.
• The solution has a bitter metallic taste and may cause a burning sensation upon contact with oral mucosa.
• SDF should not be applied in the presence of oral ulcers or stomatitis, and it can emit an unpleasant ammonia odor.
• The application process can be challenging for interproximal lesions.
• A single application is typically insufficient; reapplication is required every six months.
• There are liability concerns associated with using SDF "off-label" for caries management instead of its FDA-approved use as a desensitizing agent.
• Comprehensive informed consent is necessary, given the lack of a consensus on the standard of care for SDF application.
• Economic considerations arise when patients or parents opt for less expensive SDF treatments instead of comprehensive restorative plans.
• Coverage and reimbursement for SDF by dental insurers are not well established.

Recognizing that the use of SDF signifies a significant shift in traditional treatment planning in the U.S., a clinical protocol has been established at the University of California, San Francisco, School of Dentistry (UCSF) to ensure appropriate treatment delivery. The “UCSF Protocol for Caries Arrest using SDF” was created by the Paradigm Shift Committee and has successfully integrated SDF treatment into the dental school curriculum, making it available in UCSF student dental clinics.

The UCSF team considered specific patient populations when evaluating SDF treatment, identifying conditions that may make patients suitable candidates, such as:

• Patients with extreme caries risk, including those with:
  • Salivary dysfunction
  • Cancer treatment
  • Sjögren’s syndrome
  • Elderly patients with salivary atrophy
  • History of methamphetamine use
• Patients who cannot tolerate standard treatment due to medical or psychological issues, including:
  • Pre-cooperative children
  • Frail elderly patients
  • Severe physical or cognitive disabilities
  • Dental anxiety or phobias
  • Medical complications
  • Individuals in nursing homes or hospice care
• Patients with multiple carious lesions who cannot be treated in one session:
  • SDF can be applied during the initial diagnostic visit to stabilize caries and prevent further progression.
  • It can be used between visits for quadrants that have not yet been treated.
  • SDF can be applied during different phases of complicated cases.
• Patients with carious lesions located in hard-to-treat areas:
  • Hard-to-access interproximal crown margins
  • Lesions in furcations
  • Occlusal caries in partially erupted third molars

Based on these considerations, the UCSF Paradigm Shift Committee developed the following criteria to identify appropriate candidates for SDF treatment:

1. Extreme caries risk (xerostomia or severe early childhood caries)
2. Challenges in treatment due to medical or behavioral management issues
3. Multiple carious lesions that cannot be treated in a single visit
4. Difficult-to-treat carious lesions
5. Patients lacking access to dental care

Clinical Application Procedure

The UCSF protocol for SDF application includes the following steps:

1. Use plastic covers for countertops and a plastic-lined bib for the patient.
2. Ensure standard personal protective equipment (PPE) for both provider and patient.
3. Place one drop of SDF in a deep plastic dappen dish (avoid glass dishes).
4. Remove excess saliva using a saliva ejector.
5. Isolate the tongue and cheek with cotton gauze or rolls.
6. If the application is near the gingiva, consider using petroleum jelly with a cotton applicator.
7. Dry the affected tooth surfaces using an air syringe.
8. Utilize a microsponge to draw SDF from the dappen dish, removing excess solution on the side of the dish.
9. Apply SDF directly onto the affected tooth surface.
10. Allow SDF to absorb for up to one minute, then remove any excess with a cotton roll.
11. Rinse the area with water.
12. Dispose of gloves, cotton products, microsponges, and the dappen dish in plastic waste bags.
13. Schedule a follow-up appointment every six months for SDF retreatment.

Clinical Insights on Silver Diamine Fluoride (SDF)

Clinical studies indicate that allowing Silver Diamine Fluoride (SDF) to remain in contact with dental tissues for up to three minutes may enhance treatment outcomes. However, even with limited cooperation from younger patients, brief applications lasting only a few seconds can still achieve caries arrest. Microscopic investigations confirm that longer exposure times facilitate deeper penetration of SDF into dentinal tubules, thereby minimizing the necessity for rinsing residual SDF to avoid systemic absorption.

Regulatory Landscape

According to the California Business and Professions Code, registered dental assistants and hygienists are permitted to apply "topical fluorides" for caries control, which encompasses SDF. The Oregon Dental Board has similarly set a precedent by ruling that dental assistants and hygienists can administer SDF under their existing statutes for topical fluoride application. Supporting these rulings, the Code Maintenance Commission of the Code on Dental Procedures and Nomenclature (CDT) has introduced a new code, D1354, for SDF application, defined as “interim caries arresting medication application.” This procedure is described as a conservative method for treating active, nonsymptomatic carious lesions via topical application of a caries arresting or inhibiting agent without the mechanical removal of sound tooth structure. However, it’s important to note that the FDA has not yet approved SDF for caries control.
In 2017, the American Academy of Pediatric Dentistry (AAPD) issued a statement regarding SDF use, offering a conditional recommendation for its application: "The panel endorses the use of 38 percent SDF for arresting cavitated caries lesions in primary teeth as part of a comprehensive caries management program. Considering the low cost of the treatment and the disease burden of caries, the panel members believe the benefits of SDF application in targeted populations outweigh potential undesirable effects."

Informed Consent and Protocols

SDF application is a novel procedure in the United States and is classified as “off label,” making informed consent especially critical prior to treatment. The University of California, San Francisco (UCSF) has established a specific informed consent protocol for SDF application, which includes several essential points:

• SDF applications will be necessary every six months.
• While SDF can arrest caries progression, it does not negate the requirement for dental fillings or crowns for restoring function or aesthetics.
• The areas treated with SDF will permanently stain black, and tooth-colored fillings may discolor, with visible staining along the margin between the tooth and filling.
• UCSF provides before-and-after photographs that illustrate the permanent black stains resulting from SDF treatment.
• If SDF inadvertently comes into contact with skin or gums, it may cause a brown stain that, although harmless, cannot be removed and typically fades within one to three weeks.
• Depending on the extent and location of tooth decay, additional treatments may include fluoride varnish, fillings or crowns, extraction, or more advanced procedures.

Conclusion

Silver Diamine Fluoride represents a significant advancement in the fight against dental caries. Research has demonstrated that SDF is more effective than fluoride varnishes and comparably effective to sealants, all at a fraction of the cost—10 to 20 times less expensive. Globally, SDF has been successfully used for decades; however, its main drawback in the United States remains the aesthetic concern of dental staining. Nonetheless, SDF offers improved care for underserved populations and those unable to access or afford extensive restorative treatments. As noted by the FDA and conditionally recommended by the AAPD, SDF is a breakthrough therapy that is likely to play a pivotal role in the toolkit of U.S. dentists. The impact of SDF on the standard of care for caries treatment in both pediatric and adult patients, as well as the financial implications for dental practices, insurers, and government policies, remains to be fully understood.

Dental restorative manufacturers are now producing one-shade universal composite systems. Three examples include Tokuyama’s Omnichroma, Ultradent’s Transcend, and Kerr’s SimpliShade. The first two systems aim to replace an extensive array of composite shades—up to 20 or more—with a single composite, simplifying the placement of restorations. SimpliShade utilizes three shades (Light, Medium, and Dark) to correspond with the 16 shades of the Vita Classical shade guide.

Tokuyama Dental America has developed a dental composite restorative named Omnichroma, designed to color-match a wide variety of tooth shades. The manufacturer states that this material can match the shade of every patient’s dentition “from Vita A1 to D4.” Described as a “universal esthetic composite,” Omnichroma is intended to eliminate the need for dentists to shade match each restored tooth with a specific composite shade kept in inventory. It employs “smart chromatic technology,” allowing dentists to forego shade-taking before restoring teeth with composite.

Human tooth shades represent a very narrow range of colors within the red to yellow spectrum. In typical dental composites, the patient’s tooth shade is mimicked by adding shade-specific red and yellow dyes and pigment additives to the resin binder. Consequently, each shade of traditional composite on the standard Vita Classical shade guide requires a different color composition, necessitating individual supplies of material syringes or compules for restoration.

The principle by which Omnichroma matches existing tooth coloration differs from conventional dental composites. Its smart chromatic technology relies on the use of extremely small (260 nm), uniformly sized filler particles. Omnichroma operates on a “structural color” mechanism, whereby the material’s microspheres accurately transmit and amplify varying wavelengths of light passing through them. This results in a chameleon-like effect, enabling the material to mimic the shade of the surrounding tooth structure. The 260 nm diameter spherical filler particles are specifically designed to optimally transmit and amplify light waves in the red-to-yellow color spectrum. The resulting shade is generated by light passing through the composite from the patient’s tooth, combined with light reflected from the surrounding dentition. The microsphere composition also contributes to excellent physical properties and exceptional polishability, enhancing the shade match.

For cases involving severely darkened or amalgam-stained dentin, the Omnichroma system employs a “blocker” used as a liner to enhance shade matching. The manufacturer recommends utilizing the blocker in large restorative preparations and anterior cases as a lingual backdrop for the overlying composite. In facial or buccal applications, a marginal bevel is recommended to enhance shade matching, similar to any conventional composite approach.

Ultradent’s Transcend universal one-shade composite system is similarly designed to streamline restorative treatment and alleviate clinician stress by removing the shade-matching step from composite treatments. Ultradent describes Transcend as utilizing Resin Particle Match technology, where the resin and filler particles have refractive indices that produce high levels of translucency, facilitating blending with the surrounding tooth structure. This enhances the chameleon-like effect of the restorative by reflecting more accurate pigmentation and opacification. Ultradent advocates for the use of a single universal body shade of Transcend without the application of a blocker.

Kerr’s SimpliShade employs an Adaptive Response Technology (ART) for shade matching. Like Ultradent’s Transcend, Kerr does not recommend using a separate blocker and indicates that SimpliShade is suitable for all classes of composite restorations. SimpliShade utilizes smaller (50 nm) filler particles to improve polishability, thereby enhancing shade matching and maintaining luster over time.

Advantages of Universal Multi-Shade-Matching Composites

The benefits of using a universal multi-shade-matching composite include:

• Improved shade matching through unique optical properties
• Reduced chair time by eliminating shade matching
• Decreased operator stress by removing the shade-matching step
• Lower composite inventory requirements
• Simplified ordering and inventory control
• Prevention of rarely used shades from exceeding shelf life
• Elimination of the need to special order composite shades for patients
• Enhanced esthetics by blending restorations with adjacent teeth
• Elimination of the need to redo restorations after tooth whitening/bleaching

These new restorative materials promise to simplify composite restoration procedures and inventory management. The esthetic effectiveness, handling characteristics, and durability of these materials still require evaluation by clinicians to determine their suitability for practice.

MTA Endodontic Sealer Overview

Mineral Trioxide Aggregate (MTA) is an innovative dental material that serves as an alternative for clinicians seeking effective treatment methods in various endodontic applications. For decades, gutta percha and other endodontic sealers have been the mainstay for endodontic obturation. Additionally, materials such as amalgam, glass ionomers, Zinc-Oxide-Eugenol cement, and composite resins have been utilized for retrograde fillings and endodontic repairs. While these materials have shown success in numerous clinical scenarios, they come with certain limitations and characteristics that may not be ideal. An ideal material for conventional endodontic obturation and retrograde repair should possess the following criteria:

• Permanently seals prepared canal spaces from the supporting periodontium
• Insoluble in oral and bodily fluids
• Non-leaking and non-shrinking
• Non-resorbable and nontoxic
• Non-staining
• Easy to manipulate and predictably mixed
• Non-technique sensitive with rapid setting properties
• Distinctly radiopaque
• Adheres to dentin
• Capable of setting in a wet environment
• Biocompatible with the periodontium
• Bioactive and easily retrievable after placement and setting
• Reasonably priced

MTA, due to its distinctive formulation, addresses many of the shortcomings of the aforementioned dental materials. Although it doesn't fulfill all ideal criteria, numerous clinical studies demonstrate that MTA promotes healing and repair in cases where other endodontic materials may not be as reliable.

MTA is composed of refined Portland cement (PC) and bismuth oxide, with smaller amounts of gypsum and aluminum to provide extended clinical working time. Unlike PC, MTA contains no potassium. MTA received U.S. Food and Drug Administration (FDA) approval for use in endodontic treatment in 1998 and has since been the subject of extensive laboratory and clinical research.

Physical, Chemical & Mechanical Properties

While often referred to as a form of Portland cement, MTA's chemical and physical properties differ from those of PC, as it is a more highly refined material. It is manufactured under strict biomaterial standards and has distinct setting characteristics. MTA features a finer particle size than PC, providing a longer working time without the heavy metal contaminants common in PC mixtures. PC is more soluble and tends to develop surface cracks upon setting, with expansion that may lead to root fractures if used in dental applications. Although Portland cement is less expensive, it is not acceptable as a substitute for MTA in clinical procedures.

When mixed with sterile water at a 3:1 powder-to-liquid ratio, MTA produces calcium hydroxide and calcium silicate hydrate, forming a porous colloidal gel infused with crystals. This process results in a precipitate of calcium and calcium hydroxide at the material's surface, in contact with dentin and periodontium. The high alkalinity of this setting environment (initial pH of 10, rising to 12.5 after four hours) contributes to many of MTA’s beneficial bioactive properties. The hardness of set MTA continues to increase for up to 21 days in the presence of moisture. Electron micrographs reveal a lattice of cubic crystals interspersed with needle-like crystals within the fully set MTA surface.

While the extended working time can be advantageous, two non-ideal characteristics of MTA are its prolonged setting time and its requirement for adequate hydration to fully set. The average initial setting time exceeds 2.5 hours, which can complicate the immediate placement of buildups, posts, and other final restorations. Maintaining a high moisture environment on the MTA surface during setting is crucial for achieving optimal physical properties. Clinicians often achieve this by placing a water-soaked cotton ball on the MTA surface before temporization.

In cases of furcation repair, the push-out strength of an endodontic repair material is vital. Normal masticatory forces can dislodge repair materials in the early stages of the setting process, necessitating patient advisement against vigorous chewing on recently repaired teeth until full initial set is achieved. Adequate MTA thickness (minimum 4mm) is essential to resist early fracture or displacement.

Antibacterial & Antifungal Properties

Laboratory and clinical studies indicate that MTA demonstrates antibacterial properties against various virulent bacteria, including Staphylococcus aureus, Enterococcus faecalis, and Pseudomonas aeruginosa, through direct contact tests. While MTA shows antibacterial effects against facultative anaerobes, it is less effective against strict anaerobes. Investigations also confirm antifungal properties of MTA, with Candida albicans being susceptible when MTA is first mixed and at 24 hours post-placement. Researchers attribute these antifungal effects to the high pH at setting and the release of calcium hydroxide from the MTA.

Biocompatibility & Bioactivity

MTA is classified as a bioactive material due to its biocompatibility and its ability to promote regeneration of both hard and soft tissues. Studies show that human periodontal ligament cells attach to MTA surfaces but do not attach to gutta percha controls. Other studies demonstrate that MTA positively influences the proliferation of periodontal fibroblasts, facilitating reattachment to the root surface. MTA has also shown a favorable osteogenic effect on surrounding bone, an effect not observed with traditional endodontic materials. Moreover, MTA exhibits no neurotoxic effects on neuronal and glial cells, contrasting with amalgam, ZOE, and resin sealers, which have shown neurotoxic effects in a significant percentage of nerve cells studied.

Sealing & Microleakage Studies

Effective sealing between the cleaned and shaped root canal and the surrounding periodontium is essential for successful root canal obturation. Microleakage from residual or recurrent bacteria and toxins is a leading cause of endodontic failures, necessitating retreatment, retrograde retreatment, or extraction. Dye penetration studies have demonstrated that MTA has superior sealing properties compared to traditional root canal materials. Bacterial penetration studies indicate that MTA significantly outperforms both amalgam and ZOE cements, showing no leakage after 90 days with Staphylococcus epidermis, whereas the other two materials exhibited leakage within just six days.

Clinical Applications

MTA is currently used in various endodontic procedures, including:

• Direct pulp capping
• Indirect pulp capping
• Pulpotomy dressing
• Perforation repair
• Furcation repair
• Internal and external resorption repair
• Apical retrograde filling
• Apexogenesis (immature/open apex closure)
• Complete endodontic obturation

Research into MTA’s use as a pulp capping material shows promise in both direct and indirect applications, with studies indicating that MTA has a superior stimulating effect on pulpal cells compared to conventional calcium hydroxide preparations. In seven studies involving MTA as a pulpotomy dressing in deciduous teeth, all MTA-treated primary molars were retained without failure for periods ranging from 6 to 30 months. When compared to formocresol, MTA yielded similar retention results after a 24-month follow-up. MTA-treated teeth demonstrated more consistent and thicker dentin bridge formation than those treated with calcium hydroxide dressings.

As a retrograde apical sealing material, MTA significantly reduces periapical inflammation compared to amalgam, ZOE, and resin materials. New cementum formation was observed attaching only to MTA fillings, which also uniquely demonstrated periodontal ligament reattachment and insertion.

Studies involving MTA for treating immature/open apices have shown promising results, with MTA exhibiting cementogenic properties. Periapical tissues respond more favorably to MTA than conventional calcium hydroxide, with greater fracture resistance at one year in teeth treated with MTA as an apical seal. MTA has proven reliable and predictable in inducing root-end closure.

Complete Obturation

Following successful use of MTA in isolated endodontic repairs, the next step is the complete obturation of the entire root canal space with MTA. This approach offers potential benefits related to MTA’s excellent sealing and bioactive properties, but it also presents challenges in placement and retrieval once set.

Case studies document MTA’s application for complete canal obturation, with scanning electron microscopy and x-ray diffraction studies revealing a unique interface between MTA and the root canal's internal surfaces. A layer of hydroxyapatite crystals is deposited between MTA and dentin, creating a superior seal as the crystals penetrate and obturate individual dentinal tubules upon setting. This bioactive seal promotes healing and regeneration of the periodontium more effectively than conventional non-bioactive sealers.

In cases of refractory endodontic pathology, MTA retreatment of the entire root canal complex has yielded excellent statistical healing outcomes, replacing previous gutta percha fills that exhibited apical or coronal microleakage. This alleviates the need for more invasive surgical interventions in many instances. Moreover, teeth with complete MTA obturations have shown greater resistance to root fracture.

Advantages and Disadvantages

Researchers and clinicians continually strive for improved, more predictable endodontic obturation and repair materials. While MTA shows promise as a bioactive material with the potential to enhance treatment outcomes, its success rates are still being evaluated.

A significant drawback of conventional MTA obturation is the difficulty of retrieval if retreatment becomes necessary. Removing set MTA is akin to trying to extract Portland cement from a cleaned and shaped canal, and there is no universally accepted protocol for this process. Some success has been reported with ultrasonic instrumentation, but retrieval is particularly challenging in curved canals, often limiting retreatment options to surgical approaches. This factor should be carefully considered when recommending MTA obturation as an initial treatment choice.

MTA is rapidly accumulating substantial clinical evidence demonstrating its effectiveness and predictability in various endodontic procedures, including pulp capping, pulpotomy dressing, perforation repair, apexogenesis, and retrograde apical filling. As a result, it has become a vital addition to the clinician’s toolkit for managing endodontic pathologies.

While MTA may not satisfy all criteria for an ideal endodontic material, its advantages often outweigh its limitations in numerous clinical contexts. In contrast, traditional materials like gutta percha are generally easier to manipulate and retrieve; however, they face challenges related to coronal and apical microleakage and lack bioactive properties.

With an increasing array of FDA-approved materials available, clinicians must remain vigilant in evaluating the benefits and drawbacks of different options to ensure the most suitable material is chosen for each unique endodontic situation.

GentleWave & Enhanced Endodontic Irrigation

In recent decades, endodontics has experienced significant advancements in materials, instrumentation, and techniques, leading to improved success rates and predictability in root canal therapy. Innovations such as CBCT scanners, Nickel-Titanium files, rotary instrumentation, advanced sealers, and operating microscopes have paved the way for enhanced treatment outcomes.

A growing focus is now placed on optimizing canal irrigation and disinfection, in alignment with the American Association of Endodontists’ assertion that the goal of endodontic treatment is to foster an environment conducive to self-healing. Achieving thorough disinfection of the root canal space is crucial; however, current techniques often fall short of completely eliminating bacteria.

The GentleWave system, developed by Sonendo, Inc., aims to improve the irrigation and disinfection process within the root canal, complementing conventional cleaning, shaping, and obturation methods. This system addresses the complexities of tooth anatomy that are often not evident on standard radiographs but may be revealed through CBCT scans, highlighting intricate structures like bifurcations, trifurcations, and apical delta formations that conventional files may not adequately clean.

While the GentleWave system streamlines the irrigation process, it does not eliminate the need for a comprehensive approach to root canal therapy. Clinicians must still conduct thorough diagnoses, ensure profound anesthesia, and navigate access to all canals, particularly those that are calcified, before initiating irrigation.

A longstanding principle in endodontics emphasizes that "what you take out is more important than what you put in." Effective cleaning and disinfection of the root canal system are paramount for successful outcomes, often taking precedence over the choice of sealers and obturators. Initial mechanical cleaning and shaping facilitate access for irrigants, but it's acknowledged that current instruments cannot reach all canal walls or penetrate all anatomical complexities.

The primary endodontic irrigants used in this process include:

• Sodium Hypochlorite: Dissolves organic tissue and exhibits antimicrobial and antibiofilm properties.
• EDTA: (17% ethylenediaminetetraacetic acid) removes inorganic material and the smear layer, improving access to micro-anatomy.
• Distilled Water: Used as a clearing rinse.

The GentleWave system introduces, distributes, agitates, and circulates these irrigants through a minimally prepared root canal. Its guiding philosophy is to minimize unnecessary filing and shaping to preserve tooth structure while creating a pathway for effective irrigant flow. The system employs a single-use disposable handpiece designed to establish an airtight seal on the tooth.

Once securely attached, the GentleWave device conducts a leakage test using distilled water for 60 seconds. Following this, sodium hypochlorite solution is circulated throughout the root canal system, accompanied by a series of rinses with distilled water and EDTA irrigation, all while maintaining a flow rate of 45 mL/min to ensure thorough cleaning and disinfection within approximately 10 minutes.

Sonendo explains that the GentleWave process involves the activation of irrigants through the implosion of microbubbles, generating an acoustic wave that cleans all areas of the root system. Additionally, the system employs negative pressure to prevent extruding irrigants past the apical foramina.

While microscopic evaluations of root systems treated with GentleWave show promising cleaning results and the absence of smear layer, peer-reviewed clinical studies are still needed to conclusively demonstrate statistically significant improvements in treatment outcomes.

BlueCheck Caries Detection

According to the Centers for Disease Control and Prevention (CDC), dental caries affect over 95% of Americans during their lifetime. The BlueCheck Caries Detection and Monitoring system is an innovative diagnostic tool designed to assist dental professionals in detecting caries by identifying demineralized enamel areas that traditional visual and tactile examinations may overlook. Developed and manufactured by Incisive Technologies in Australia, BlueCheck received FDA 510(k) clearance and approval, making it available in the United States as of September 2023. The product is also protected under European patent #2 547 311 B1.

Incisive Technologies describes BlueCheck as a "purpose-designed biomolecule" composed of a protein, a linker, and a blue dye. This design allows the biomolecule to utilize natural hydroxyapatite-binding chemistry to attach selectively to sites of enamel demineralization. BlueCheck binds specifically to porous enamel surfaces and subsurface lesions, indicating active carious lesions and providing a visible blue color to assist dental professionals in measuring disease objectively. Dr. Jonathan Magnum, the Chief Scientific Officer of Incisive Technologies and inventor of the technology, emphasizes that “BlueCheck selectively and reversibly binds to sites of enamel demineralization. Healthy enamel and arrested carious lesions do not turn blue.” The product aims to provide objective evidence of caries lesion status to support clinicians in routine examinations, diagnosis, treatment planning, and ongoing monitoring.

Initially developed to detect and monitor enamel demineralization during orthodontic treatments—when patients may struggle with oral hygiene—BlueCheck serves as a preventative tool during periods when smooth enamel surfaces are particularly vulnerable to rapid demineralization and caries development. Early studies involved human molars and premolars extracted for various reasons, including periodontal disease or orthodontic purposes. The teeth underwent treatments such as superficial enamel removal or demineralization using lactic acid (pH 4.6) for seven days. A baseline for demineralization was established using quantitative light-induced fluorescence, after which BlueCheck was applied and evaluated for staining. Notably, the BlueCheck dye did not appear on natural or roughened tooth surfaces, being observed only by trained clinicians on demineralized teeth. This resulted in a 100% sensitivity score for the BlueCheck caries detection system, while control surfaces that were not demineralized showed no staining, yielding a specificity score of 100% for the technique.

The early diagnosis and prevention of enamel demineralization lesions are crucial objectives in preventive dentistry. By serving as an adjunctive technique, BlueCheck offers additional diagnostic assistance in identifying initial enamel lesions, similar to how plaque-disclosing solutions aid in oral hygiene education and instruction. This is particularly vital during traditional orthodontic treatments, where plaque and biofilm can accumulate around brackets and bands.
Historically, caries detection has primarily relied on subjective visual and tactile feedback, which can vary based on a clinician's judgment and experience. Such diagnostic techniques are operator-dependent, often leading to inconsistencies across different practitioners and offices. Consequently, there has been a push for operator-independent detection methods that utilize fluorescence and bioluminescence for more objective and quantitative enamel lesion diagnosis. However, these methods have not been widely adopted in clinical settings due to their associated costs, time requirements, and usability issues.

BlueCheck's mechanism of action centers around the loss of hydroxyapatite-binding proteins in enamel porosities. The BlueCheck dye exploits the natural hydroxyapatite-binding properties of hemoglobin to target porous, protein-deficient areas of enamel. This specificity allows BlueCheck to differentiate between healthy and demineralized enamel, leaving a visible blue dye on lesions at their earliest stages, all without the need for additional equipment. Composed of a protein (hemoglobin) bonded to a dark blue dye (amido black), BlueCheck binds to the porous hydroxyapatite through an electrostatic reaction, enabling easy reversibility and removal through brushing with a sodium-lauryl sulfate (detergent) toothpaste.

Control samples that were not demineralized underwent multiple BlueCheck applications to confirm the absence of blue dye, resulting in 100% reproducibility on caries-free smooth surfaces. Similarly, BlueCheck staining on demineralized surfaces consistently reproduced after cleaning and reapplication, demonstrating a 100% repeatability rate.
While visual and tactile methods remain standard for detecting enamel demineralization and carious lesions in most dental practices, these techniques can vary based on the clinician's individual experience and sensitivity. BlueCheck presents itself as a promising adjunctive procedure for objectively diagnosing enamel demineralization, requiring no additional hardware or software and minimal training for implementation. Unlike dentinal caries-detecting materials that target infected dentin and depolymerized collagen to facilitate minimal dentin removal during cavity preparations, BlueCheck specifically addresses enamel demineralization.

However, there are drawbacks to the BlueCheck technique, such as the lack of quantifiable data regarding the presence of demineralized enamel. Currently, BlueCheck functions as a binary diagnostic tool, indicating whether enamel is mineralized or demineralized but not providing insights into the severity or extent of demineralization. For documentation purposes, clinicians would need to take photographs to record BlueCheck findings.

Despite these limitations, BlueCheck stands out as a noninvasive, nondestructive, painless, and relatively inexpensive technique with great potential as a caries detection system. Similar to plaque-disclosing solutions, it offers a significant clinical opportunity for practitioners to enhance patient education and motivate better home care practices to prevent caries.

---

Quiz For Advances in Dentistry